My Profile
Edit Profile
My Follows
My Wires
My Drafts
Analytics
Email Preferences
Sign Out
home
most popular
Latest
Buy Hold Sell
Listed Series 2024
Series
Alternatives in Focus
Buy Hold Sell
Expert Insights
Fund in Focus
Income Series
Listed Series
Livewire Live
Meet The Adviser
Meet The Investor
Outlook Series
Rapid Fire
Reporting Season
Signal or Noise
Success and More Interesting Stuff
The Pitch
The Rules of Investing
Undiscovered Funds
Views from the Top
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Assets
Property
Contributors
Find Funds
About Livewire
Careers
Contact Us
Write a Wire
Notifications
Loading...
Write a wire
Account
My profile
My follows
My wires
My drafts
Analytics
Email preferences
Company
About Livewire
Contact us
Sign out
Sign In
Join Free
Latest
Buy Hold Sell
Listed Series 2024
Series
Alternatives in Focus
Buy Hold Sell
Fund in Focus
Livewire Live
Meet The Investor
Outlook Series
Rapid Fire
Reporting Season
Signal or Noise
Success and More Interesting Stuff
The Pitch
The Rules of Investing
Views from the Top
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Assets
Property
Find funds
mesoblast
Latest news and analysis on mesoblast
Equities
August 31, 2020 16:48
Game changing potential for loss-making Mesoblast
Melbourne-based biotech Mesoblast will achieve a world-first that could open up its drug pipeline to a massive market if it wins US Food and Drug Administration...
Glenn Freeman
Livewire Markets
August 31, 2020 16:48
September 27, 2016 14:28
A biotech that's been
misunderstood
MSB
Mesoblast Ltd
ASX:MSB
Followed by
307
people
MSB
Mesoblast Ltd
ASX:MSB
Followed by
307
people
Livewire Exclusive
Livewire Markets
September 27, 2016 14:28
September 06, 2016 06:41
Mesoblast (ASX: MSB) - Why I expect Team Silviu can make a strong comeback
Stuart Roberts
Pitt Street Research and NDF Research
September 06, 2016 06:41
Advertisement
November 24, 2013 22:52
Legislation just passed in Japan could accelerate Mesoblast's (MSB) entry into the largest market outside of the US
James Marlay
Livewire Markets
November 24, 2013 22:52
4
most
popular
Equities
Buy Hold Sell: 4 undiscovered gems as gold prices hit record
highs
Buy Hold Sell,
Livewire Markets
Equities
Bizarre: The $11m microcap sitting on a $21m cash pile
Glenn Freeman,
Livewire Markets
Equities
Why Ben Clark is taking profits on growth stocks (and where he's putting that money to
work)
The Rules of Investing,
Livewire Markets
Equities
Why Australian small caps are looking promising and three stocks to
watch
Sara Allen,
Livewire Markets
view all
Advertisement
